+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Specialty Pharmaceuticals Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • ID: 4807792
  • Report
  • June 2019
  • Region: Global
  • 101 pages
  • 360iResearch
UP TO OFF
until Jul 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • CIGNA Pharmacy Management
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Endo Pharmaceuticals Inc.
  • ENESI
  • Humana Pharmacy, Inc.
  • MORE
The Global Specialty Pharmaceuticals Market is expected to grow from USD 19,027.67 Million in 2018 to USD 182,751.66 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 38.15%.

The positioning of the Global Specialty Pharmaceuticals Market vendors in the FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).

The report explores the recent significant developments by the leading vendors and innovation profiles in the Global Specialty Pharmaceuticals Market including are CVS Health Corporation, Endo Pharmaceuticals Inc., Kroger Specialty Pharmacy, Inc., McKesson Corporation, Midatech Pharma PLC, Accredo Health Group, Inc., Avella Specialty Pharmacy, Inc., CIGNA Pharmacy Management, Diplomat Pharmacy, Inc., ENESI, Humana Pharmacy, Inc., Hyphens Pharma Pte Ltd., UnitedHealth Group Incorporated, US WorldMeds, LLC, and Walgreens Boots Alliance, Inc..

On the basis of Type, the Global Specialty Pharmaceuticals Market is examined across CNS, Infectious diseases, Momen’s health, Oncology, and Respiratory.

On the basis of Product, the Global Specialty Pharmaceuticals Market is examined across Oral Pharmaceuticals, Parenteral Pharmaceuticals, and Transdermal Pharmaceuticals.

On the basis of Distribution Channel, the Global Specialty Pharmaceuticals Market is examined across Hospitals & Care Providers, Online Mode, Retail Pharmacies, and Specialty Pharmacies.

For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.

In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

The market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Specialty Pharmaceuticals Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Specialty Pharmaceuticals Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Specialty Pharmaceuticals Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Specialty Pharmaceuticals Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Specialty Pharmaceuticals Market

The report answers questions such as:

1. What is the market size of the Specialty Pharmaceuticals market?
2. What are the factors that affect the growth in the Global Specialty Pharmaceuticals Market over the forecast period?
3. What is the competitive position in the Global Specialty Pharmaceuticals Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Specialty Pharmaceuticals Market?
5. What are the opportunities in the Global Specialty Pharmaceuticals Market?
6. What are the modes of entering the Global Specialty Pharmaceuticals Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • CIGNA Pharmacy Management
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Endo Pharmaceuticals Inc.
  • ENESI
  • Humana Pharmacy, Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. FPNV Positioning Matrix
2.3.2.1. Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support

3. Executive Summary
3.1. Outlook in the Specialty Pharmaceuticals Market
3.1.1. Specialty pharmaceuticals are representing an increasing share of total drug expenditures by existing health plans
3.1.2. Ongoing clinical trial pipeline
3.1.3. As the prices of generics drugs shades, pharma companies shift focus to specialty drugs
3.2. Opportunities in the Specialty Pharmaceuticals Market

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing demand for specialty drugs to treat complex or serious chronic conditions
4.2.1.2. Increased reimbursement through the medical benefit, and pharmacy benefit
4.2.1.3. Specialty pharmacy providers collaborating with pharma/biotech manufacturers, payers, MCOs and patients
4.2.1.4. Attractive prospects for biopharmaceutical companies from both business and medical innovation perspective
4.2.2. Restraints
4.2.2.1. Cost sharing discourages the use leading to adverse health outcomes
4.2.2.2. Growth in premium costs
4.2.3. Opportunities
4.2.3.1. Retailers involvements in specialty market and several chains operate their own specialty pharmacy divisions
4.2.3.2. Stimulated diagnostic research
4.2.3.3. Vendors offering compliance programs, reimbursement assistance programs and distribution channels
4.2.3.4. Growth of enhanced information technologies in the specialty sector
4.2.3.5. Value-added programs targeting physicians, nurses, patients and caregivers
4.2.4. Challenges
4.2.4.1. Less focus on development of low-cost generic equivalents of specialty drugs
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Regulatory Framework
4.4.2. Value Chain Analysis
4.4.3. Patent Analysis and Trend

5. Global Specialty Pharmaceuticals Market, by Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. CNS
5.4. Infectious diseases
5.5. Momen's health
5.6. Oncology
5.7. Respiratory

6. Global Specialty Pharmaceuticals Market, by Product
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Oral Pharmaceuticals
6.4. Parenteral Pharmaceuticals
6.5. Transdermal Pharmaceuticals

7. Global Specialty Pharmaceuticals Market, by Distribution Channel
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Hospitals & Care Providers
7.4. Online Mode
7.5. Retail Pharmacies
7.6. Specialty Pharmacies

8. Global Specialty Pharmaceuticals Market, by Geography
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom

9. Competitive Landscape
9.1. FPNV Positioning Matrix for Global Specialty Pharmaceuticals Market
9.2. Market Vendor Ranking Analysis for Global Specialty Pharmaceuticals Market
9.3. Competitive News Feed Analysis for Global Specialty Pharmaceuticals Market

10. Company Usability Profiles
10.1. CVS Health Corporation
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Endo Pharmaceuticals Inc.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Kroger Specialty Pharmacy, Inc.
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. McKesson Corporation
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Midatech Pharma PLC
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Accredo Health Group, Inc.
10.7. Avella Specialty Pharmacy, Inc.
10.8. CIGNA Pharmacy Management
10.9. Diplomat Pharmacy, Inc.
10.10. ENESI
10.11. Humana Pharmacy, Inc.
10.12. Hyphens Pharma Pte Ltd.
10.13. US WorldMeds, LLC
10.14. UnitedHealth Group Incorporated
10.15. Walgreens Boots Alliance, Inc.

11. Appendix
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • CVS Health Corporation
  • Endo Pharmaceuticals Inc.
  • Kroger Specialty Pharmacy, Inc.
  • McKesson Corporation
  • Midatech Pharma PLC
  • Accredo Health Group, Inc.
  • Avella Specialty Pharmacy, Inc.
  • CIGNA Pharmacy Management
  • Diplomat Pharmacy, Inc.
  • ENESI
  • Humana Pharmacy, Inc.
  • Hyphens Pharma Pte Ltd.
  • UnitedHealth Group Incorporated
  • US WorldMeds, LLC
  • Walgreens Boots Alliance, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll